The Access to Family Building Act establishes a federal statutory right for individuals to access assisted reproductive technology (ART) and related medical care, for providers to deliver ART and related information, and for insurers to cover such services. It bars prohibitions or "unreasonable" limits on that access, authorizes the Attorney General and private parties to sue to stop violations, and directs HHS to issue implementation regulations within a year.
The bill matters because it substitutes a federal baseline for state restrictions on fertility care, reserves broad judicial remedies (including injunctions and fee-shifting) to enforce that baseline, and contains an unusually expansive preemption clause that displaces conflicting state and some federal laws unless later federal statutes say otherwise. Compliance officers, health systems, state regulators, and payors will want to map how existing state rules and licensing regimes intersect with this new federal standard.
At a Glance
What It Does
The bill creates enforceable statutory rights: patients may obtain and continue ART, providers may perform and counsel on ART, and insurers may elect to cover ART. It gives the Attorney General authority to sue governments that enact or apply prohibitions or unreasonable restrictions, and it creates a private right of action for affected individuals and providers with mandatory fee-shifting for prevailing plaintiffs.
Who It Affects
Fertility clinics and clinicians, hospitals that offer ART-adjacent services, patients seeking fertility care (including those using gamete or embryo services), state and local governments with restrictions on ART, and HHS as the implementing regulator. Insurers and employers that sponsor health plans will face a changed legal backdrop even though the bill does not itself mandate coverage.
Why It Matters
The Act replaces varied state approaches with a federal floor for ART access and invites rapid federal litigation to enforce that floor. The broad preemption language — which expressly references and displaces the Religious Freedom Restoration Act — and the limited carve-outs for state safety rules create a new national regulatory axis for reproductive medicine.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill sets a federal baseline that protects access to assisted reproductive technology and the medical care surrounding it. It defines covered actors and services broadly, using the federal definition of assisted reproductive technology from the 1992 clinic statute and a sweeping definition of "health care provider" that covers individuals and entities who deliver ART or related counseling, referrals, items, or services.
Patients gain a statutory right to receive ART, continue an ongoing treatment under a written plan, and control the disposition of their reproductive genetic materials, subject to the Act’s limited exceptions.
Enforcement is both public and private. The Attorney General can sue states, localities, or government officials who enact or enforce prohibitions or "unreasonable" limitations on ART and seek courts’ orders to set aside those measures.
The bill also gives individuals and entities a direct private right of action against state or local officials and allows providers to sue on behalf of themselves, their staff, or affected patients. Courts may issue temporary, preliminary, or permanent injunctions, and prevailing plaintiffs are entitled to litigation costs and reasonable attorneys’ fees; plaintiffs are protected from liability for costs or fees when their claims are non-frivolous.At the same time, the bill preserves a narrow role for state medical and facility safety regulation: states may still enforce licensing and health-and-safety requirements so long as those rules genuinely advance patient safety and cannot be achieved by less restrictive alternatives.
The Act does not alter state insurance laws — it neither compels coverage nor precludes states from setting insurance standards — but it states that nothing in the Act modifies existing state insurance law. Finally, the Secretary of Health and Human Services must issue implementing regulations within one year, which will be the primary vehicle to define terms like "unreasonable limitation" and the boundaries of the provider definition.
The Five Things You Need to Know
The Attorney General may sue any State, local government, or official that enacts or enforces a law or rule that prohibits or unreasonably limits access to ART and seek to have that measure set aside by a court.
Private parties — including patients, providers, and entities harmed by a violation — can bring civil suits against state or local officials; prevailing plaintiffs must receive litigation costs and reasonable attorney’s fees, and plaintiffs are insulated from fee liability in any non-frivolous action.
The bill requires the Secretary of Health and Human Services to issue regulations to implement the Act within one year of enactment, making HHS the central administrative interpreter of key terms and exceptions.
State health-and-safety regulations remain enforceable only if they advance patient safety and that objective cannot be advanced by a less restrictive alternative; the Act explicitly preserves this narrow safety exception.
The Act contains an expansive preemption clause that applies to federal and state law — specifically stating it displaces conflicting provisions notwithstanding the Religious Freedom Restoration Act — and declares subsequently enacted federal statutes subject to this Act unless they expressly exclude it.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Identifies the statute as the "Access to Family Building Act." This is the naming clause that will appear in citations and legislative references; no substantive effect beyond the title.
Definitions for reach and scope
Adopts a narrow statutory glossary that is legally consequential. It imports the federal ART definition from the 1992 Clinic Success Rate and Certification Act and uses a broad, catch-all definition of "health care provider" to cover clinicians, support staff, pharmacies, and any entity that provides ART services or related counseling, items, or referrals. Those definitions determine who can assert rights and who can be protected by the Act's defenses and enforcement tools.
Findings and purpose
Recites constitutional bases (Commerce Clause, Fourteenth Amendment enforcement, Necessary and Proper Clause) and frames Congress’s intent: to remove burdensome or unjustified limitations on fertility care. Those findings are a blueprint for judicial interpretation: courts will likely read the Act as addressing interstate commerce and individual liberty interests, and judges will use the stated purposes when assessing whether a state restriction is "unreasonable."
Substantive rights and enforcement
Enumerates statutory rights for patients (to access and continue ART and control reproductive materials), for providers (to perform and counsel on ART), and for insurers (to cover such services). It creates parallel enforcement paths: DOJ enforcement, broad private rights of action (including provider suits on behalf of patients), injunctive relief, fee-shifting to prevailing plaintiffs, federal jurisdiction with removal rights, and immediate reviewability of remand orders. This section is the enforcement engine — it both defines harms and gives litigants powerful remedies.
Preemption and defensive use
Contains sweeping preemption language covering federal and state law and expressly notes that the Act supersedes provisions "notwithstanding" the Religious Freedom Restoration Act. It also says future federal statutes are subject to the Act unless they explicitly exclude it. Section 5 further allows the Act to be raised as a defensive shield in litigation when an individual or entity is accused under a conflicting state or local limitation.
Severability
A standard severability clause: if any provision is held unconstitutional, the remainder remains in force. This increases the bill’s litigation resilience by signaling Congress’s intent that surviving provisions continue to operate even if parts are invalidated.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Patients seeking ART (including those using gametes or embryos): The Act creates a federal right to obtain and to continue fertility treatments and preserves control over reproductive genetic materials, reducing the risk that state restrictions will block access.
- Fertility clinics and ART providers: Providers gain an express federal right to perform and counsel on ART and a cause of action to challenge restrictive state and local measures, which lowers the regulatory risk of local prohibition.
- Clinicians and allied health staff involved in ART services: The broad provider definition shields staff from licensing or credentialing denials tied solely to their provision of ART when those denials are pretextual.
- National payors and insurers willing to cover ART: While not compelled to cover, insurers get an explicit statutory right to offer coverage without that right being undermined by conflicting local prohibitions.
- Organizations supporting reproductive access (legal clinics, civil-rights groups): The private-right-of-action and fee-shifting create a viable litigation path to enforce the federal standard.
Who Bears the Cost
- State and local governments with restrictive ART laws: They face litigation risk and potential injunctions, as well as the expense of defending laws likely to be challenged in federal court.
- Regulatory bodies that oversee medical licensing: Agencies must reconcile existing licensing or disciplinary frameworks with a federal right to provide ART, potentially altering enforcement priorities and administrative processes.
- Healthcare providers in states with conflicting rules: Clinics and providers may face a complex compliance environment and legal uncertainty while parallel state and federal claims proceed; defending or bringing suits will impose resource costs.
- HHS and federal agencies: HHS must draft implementing regulations within one year, absorb administrative costs, and will be the central arbiter of ambiguous statutory terms, creating rulemaking and enforcement resource demands.
- Private litigants and courts: The Act is likely to generate litigation (both defensive and offensive), increasing caseloads in federal courts and creating downstream costs for affected parties even where plaintiffs prevail.
Key Issues
The Core Tension
The central dilemma is between creating a uniform federal protection for access to assisted reproductive technology and preserving traditional state authority to regulate medical practice and protect public health; the bill resolves that dilemma by prioritizing access and federal enforcement while carving out only a narrow, litigable safety exception — a choice that protects individual access but invites legal fights over federal reach, religious objections, and the meaning of safety-based regulation.
The bill's broad protections hinge on inherently vague standards. Key terms such as "unreasonable limitation" and the contours of what requirements are "more burdensome than medically comparable procedures" will fall to courts and to HHS rulemaking to define.
That creates a period of legal uncertainty: providers and states will not know the limits of permissible safety regulations until litigation and regulations clarify those standards.
The preemption clause is unusually expansive and explicit — it displaces conflicting state law "notwithstanding" RFRA and subjects subsequent federal statutes to this Act unless they opt out. That design raises separation-of-powers and federalism questions: courts will have to decide whether Congress legitimately exercised commerce or Fourteenth Amendment powers to reach areas traditionally governed by state medical licensing and regulation.
The safety carve-out narrows the preemption somewhat, but it conditions permissive state rules on a least-restrictive-alternative test that is itself likely to be litigated.
Finally, the Act's enforcement framework favors plaintiffs by awarding fees and costs to prevailing plaintiffs and shielding non-frivolous plaintiffs from fee liability. That fee structure lowers the financial barrier to challenges but could also encourage high-volume or strategic litigation.
HHS's forthcoming regulations will be consequential; until they arrive, stakeholders must navigate a legal environment driven more by litigation posture than settled regulatory guidance.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.